DiscoverDaily Medical NewsIs vaccine delivery always a money loser? FDA panel backs purified EPA for heart risk
Is vaccine delivery always a money loser? FDA panel backs purified EPA for heart risk

Is vaccine delivery always a money loser? FDA panel backs purified EPA for heart risk

Update: 2019-11-18
Share

Description

Are you operating in the black when it comes to vaccine administration?

By Doug Brunk

 

Follow these tips to ensure your practice isn’t losing money on vaccine delivery.

 

*  *  *  

You can take the MDedge Podcasts survey by clicking here.

*  *  *  

Other news:

 

FDA panel supports Vascepa expanded indication for CVD reduction

Icosapent ethyl (Vascepa), purified eicosapentaenoic acid, got unanimous support from an FDA panel for a new indication of reducing CVD events.

 

Vaping-linked lung injury: 2,172 cases, 42 deaths

Forty-two deaths from EVALI have been confirmed in 24 states and the District of Columbia.

 

Open enrollment 2020: HealthCare.gov activity down from last year

Nevada opened its own exchange this year and moved off the federal system.

 

Survey asks adults: How likely are you to develop dementia?

Adults are worried about dementia and will do anything to prevent it. Except talk to their doctor.

 

You can contact the MDedge Daily Medical News by emailing us at podcasts@mdedge.com or following us on Twitter at @MDedgeTweets.

Comments 
loading
In Channel
loading
Download from Google Play
Download from App Store
00:00
00:00
1.0x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Is vaccine delivery always a money loser? FDA panel backs purified EPA for heart risk

Is vaccine delivery always a money loser? FDA panel backs purified EPA for heart risk

MDedge